IRIS
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.730
AS - Asia 8.253
EU - Europa 1.879
SA - Sud America 1.477
AF - Africa 156
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.482
SG - Singapore 5.147
CN - Cina 1.449
BR - Brasile 1.227
VN - Vietnam 714
IE - Irlanda 343
IT - Italia 342
FI - Finlandia 277
DE - Germania 274
HK - Hong Kong 251
GB - Regno Unito 170
IN - India 147
CA - Canada 106
AR - Argentina 103
BD - Bangladesh 103
MX - Messico 81
FR - Francia 79
RU - Federazione Russa 73
IQ - Iraq 66
SE - Svezia 54
PL - Polonia 51
ES - Italia 49
EC - Ecuador 48
ID - Indonesia 45
JP - Giappone 43
TR - Turchia 43
ZA - Sudafrica 40
PH - Filippine 31
PK - Pakistan 31
NL - Olanda 29
CZ - Repubblica Ceca 27
UA - Ucraina 25
SA - Arabia Saudita 23
CO - Colombia 21
MA - Marocco 21
AU - Australia 20
MY - Malesia 20
NG - Nigeria 20
UZ - Uzbekistan 20
EG - Egitto 19
VE - Venezuela 18
PE - Perù 17
AE - Emirati Arabi Uniti 15
LT - Lituania 15
JO - Giordania 13
KE - Kenya 13
NP - Nepal 13
UY - Uruguay 13
CL - Cile 12
TN - Tunisia 12
DO - Repubblica Dominicana 11
HN - Honduras 11
AZ - Azerbaigian 10
IL - Israele 10
PT - Portogallo 10
DZ - Algeria 9
PY - Paraguay 9
AT - Austria 7
BO - Bolivia 7
AL - Albania 6
BH - Bahrain 6
ET - Etiopia 6
JM - Giamaica 6
OM - Oman 6
TT - Trinidad e Tobago 6
AO - Angola 5
CR - Costa Rica 5
HU - Ungheria 5
KG - Kirghizistan 5
KR - Corea 5
KZ - Kazakistan 5
NI - Nicaragua 5
PA - Panama 5
TH - Thailandia 5
BE - Belgio 4
BY - Bielorussia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
KW - Kuwait 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
CI - Costa d'Avorio 2
DK - Danimarca 2
DM - Dominica 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
Totale 20.496
Salva come PNG Salva come JPEG
Città #
Singapore 2.098
Ashburn 1.668
San Jose 1.409
Dallas 1.354
The Dalles 828
Shanghai 697
New York 501
Boardman 463
Dublin 342
Helsinki 275
Beijing 267
Los Angeles 264
Hong Kong 238
Ho Chi Minh City 230
Hanoi 163
Santa Clara 156
Falkenstein 123
São Paulo 103
Seattle 87
Buffalo 71
London 62
Phoenix 57
Naples 51
Assago 50
Da Nang 50
Chandler 49
Milan 48
Warsaw 47
Orem 45
Moscow 42
Montreal 41
Chennai 38
Rio de Janeiro 38
Chicago 36
Brooklyn 33
Council Bluffs 33
Tokyo 32
Johannesburg 30
Brasília 27
Dhaka 27
Mexico City 27
Boston 25
Haiphong 25
Curitiba 24
Atlanta 23
Belo Horizonte 23
Charlotte 22
Stockholm 22
Toronto 22
Baghdad 21
Wilmington 21
Denver 20
Frankfurt am Main 20
San Francisco 20
Manchester 19
Benin City 18
Guayaquil 18
Tashkent 18
Brno 17
Rome 17
Sydney 16
Ankara 15
Houston 15
Pune 15
Campinas 14
Guarulhos 14
Munich 14
Hangzhou 13
Paris 13
Quito 13
Erbil 12
Fortaleza 12
Nairobi 12
Salvador 12
Amsterdam 11
Lima 11
Montevideo 11
Ninh Bình 11
Porto Alegre 11
Santo André 11
Shijiazhuang 11
Thái Bình 11
Amman 10
Baku 10
Biên Hòa 10
Lawrence 10
Mumbai 10
Praia Grande 10
Princeton 10
Ribeirão Preto 10
Buenos Aires 9
Cairo 9
Chengdu 9
Guangzhou 9
Hillsboro 9
Hải Dương 9
Kuala Lumpur 9
Maceió 9
Pasadena 9
Reston 9
Totale 13.043
Salva come PNG Salva come JPEG
Nome #
100 years of respiratory medicine : Pneumonia 643
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 378
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 132
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 114
Mapping the human genetic architecture of COVID-19 107
COVID-19 in Immunocompromised Patients: A Systematic Review 105
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 105
Cardiovascular Complications in Community-Acquired Pneumonia 97
Community-acquired pneumonia 91
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 89
A 13-year-old female with shortness of breath and pleuritic chest pain 88
A comprehensive approach to lung function in bronchiectasis 88
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis 87
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 86
A pathway to keep all lifelong learners up to date: The ERS continuing professional development programme 86
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 83
COVID-19 in lung transplant recipients: A case series from Milan, Italy 80
Treatable traits in interstitial lung diseases: a call to action 79
Quando ospedalizzare un paziente con polmonite acquisita in comunità 78
Diagnosis and Initial Investigation of Bronchiectasis 77
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 76
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 74
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults 73
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 73
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study 73
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 73
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 73
A 61-year-old female with chronic cough and purulent sputum 72
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 72
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE 71
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 71
Cardiovascular side-effects of common antibiotics 70
Post-COVID-19 sequelae 69
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group 69
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 68
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 67
COVID-19 multidisciplinary high dependency unit: the Milan model 67
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 67
What is the best technique to extract bacterial DNA from sputum? 67
Lung Ultrasound in the Diagnosis and Follow-up of Community-Acquired Pneumonia : A Prospective, Multicenter, Diagnostic Accuracy Study 67
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 66
Comparison of different conditions for DNA extraction in sputum - a pilot study 66
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 66
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD 66
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 66
Williams-Campbell Syndrome Case Series and Discordant Twins 65
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 65
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 65
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 63
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 63
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia 63
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 63
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 63
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet 63
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 62
Maternal and fetal outcomes in multiparous women with Cystic Fibrosis 62
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 61
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 61
Detection and Classification of Bronchiectasis Through Convolutional Neural Networks 60
Long-Term Outcomes in Severe Community-Acquired Pneumonia 59
How to Identify Causes and Predisposing Factors in Bronchiectasis 59
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP 59
Antibiotics for lung disease and cancer 59
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia 59
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 59
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 59
The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis 58
O papel da neutropenia no prognóstico do doente oncológico com pneumonia adquirida na comunidade = The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 58
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis 58
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) 58
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 58
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study 58
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 58
A worldwide look into long COVID-19 management: an END-COVID survey 57
Respiratory failure in COVID-19: a patient's perspective and clinical cases 57
Site of care and multidisciplinary approach 57
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 56
Neutrophil elastase in bronchiectasis 56
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis 56
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 56
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 56
Towards tuberculosis elimination: an action framework for low-incidence countries 55
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 55
Reassessing the Landscape of Viral Respiratory Infections After the COVID-19 Pandemic 55
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 54
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials 54
ERS/ECDC statement : European Union standards for tuberculosis care, 2017 update 54
Management of hospitalised adults with coronavirus disease-19 (COVID-19): A European Respiratory Society living guideline 54
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 54
Protease-Antiprotease Imbalance in Bronchiectasis 54
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 54
Bronchiectasis and Aspergillus: how are they linked? 54
Quinine treatment in severe Plasmodium falciparum malaria in children. A Holter monitoring 54
Life-threatening complications in ophthalmic surgery: a systematic review 54
Empirical Coverage of Methicillin-Resistant Staphylococcus aureus in Community-Acquired Pneumonia : Those Who Do Not Remember the Past Are Doomed to Repeat It 54
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 54
Walking the path of treatable traits in interstitial lung diseases 53
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group 53
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 53
The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis 53
Totale 7.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202260 0 1 2 4 0 0 0 3 8 20 17 5
2022/2023595 25 8 19 9 16 5 55 14 43 65 322 14
2023/20243.347 221 157 794 191 171 607 220 92 39 143 295 417
2024/20254.305 119 23 40 88 100 515 237 236 938 1.117 455 437
2025/202612.666 1.773 857 1.264 956 432 686 3.569 576 620 854 534 545
Totale 21.017